Sign In
Get Clay Free →

Suggestions

    Jousseaume Etienne

    Head Market Access Cell and Gene Europe at Novartis

    Etienne Jousseaume is the Head of Market Access for Cell and Gene Therapy in Europe at Novartis, a leading global healthcare company. In this role, he is responsible for developing and implementing strategies to ensure that innovative cell and gene therapies are accessible to patients across Europe. His work involves collaborating with various stakeholders, including healthcare systems and payers, to create frameworks that facilitate patient access to these advanced treatments.1

    Jousseaume has a significant background in the pharmaceutical industry, particularly in market access and oncology. He has contributed to multiple research projects and has authored various publications related to cell and gene therapy.2 His expertise is particularly relevant in the context of Novartis's efforts to lead the market in cell and gene therapies, such as CAR-T treatments, which are designed for personalized medicine approaches.3

    He is based in Basel, Switzerland, where Novartis's global headquarters is located. His professional journey reflects a commitment to enhancing patient access to innovative therapies, aligning with Novartis's mission to deliver transformative healthcare solutions worldwide.14

    Highlights

    Stefan Hendriks - Global Head Cell & Gene, Novartis Oncology

    Related Questions

    What are Etienne Jousseaume's key achievements at Novartis?
    How has Etienne Jousseaume contributed to the development of cell and gene therapies in Europe?
    What strategies has Etienne Jousseaume implemented for market access in cell and gene therapies?
    Can you provide examples of Etienne Jousseaume's research works at Novartis?
    How does Etienne Jousseaume's role at Novartis compare to other leaders in the cell and gene therapy field?
    Jousseaume Etienne
    Add to my network

    Location

    Basel Metropolitan Area